CD4+ CAR T-cell expansion is associated with response and therapy related toxicities in patients with B-cell lymphomas.

Bone Marrow Transplant · 2023 · PMC10471494 · PMID 37330601

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

borderline significantp = 0.090so close (0.05 < p ≤ 0.1)

For AUC0-28d we observed a trend that higher CD4+ CAR T-cell levels were associated with CR (b = 86.9 μl/l, 95% CI = −13.6–187.4, p = 0.090, borderline significant) (Fig. 1e ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.